| Placental sFLT1 is associated with complement activation and syncytiotrophoblast damage in preeclampsia |
8 |
| The association between calcium supplement and preeclampsia and gestational hypertension: a systematic review and meta-analysis of randomized trials |
8 |
| Increased circulating trimethylamine N-oxide plays a contributory role in the development of endothelial dysfunction and hypertension in the RUPP rat model of preeclampsia |
8 |
| New insight into the role of long non-coding RNAs in the pathogenesis of preeclampsia |
5 |
| Investigation of elevation as a risk factor for hypertensive disorders of pregnancy among Colorado women between 2007 and 2015 |
4 |
| Protective effect of vitamin D supplementation in a rat modal of preeclampsia: a possible implication of chemerin |
4 |
| External validation of prognostic models for preeclampsia in a Dutch multicenter prospective cohort |
4 |
| ADAMTS and 13 levels in maternal blood, cord blood, and placenta in preeclampsia |
4 |
| Preeclampsia knowledge among women in Utah |
4 |
| Changes in endothelial function, arterial stiffness and blood pressure in pregnant women after consumption of high-flavanol and high-theobromine chocolate: a double blind randomized clinical trial |
4 |
| Association between hypertensive disorders complicating pregnancy and risk of placenta accreta: a meta-analysis and systematic review |
4 |
| Alteration in methylation level at differential methylated regions of MEST and DLK1 in fetus of preeclampsia |
3 |
| Early pregnancy protein multiplex screening reflects circulating and urinary divergences associated with the development of preeclampsia |
3 |
| Prognostic value of serum soluble FMS-like tyrosine kinase (sFlt-1) levels in pre-eclampsia and eclampsia; a prospective cohort study |
3 |
| Role of vitamin D in influencing angiogenesis in preeclampsia |
3 |
| The importance of proteinuria in preeclampsia and its predictive role in maternal and neonatal outcomes |
3 |
| Incidence and outcomes of eclampsia: a single-center 30-year study |
3 |
| The reduction of melatonin levels is associated with the development of preeclampsia: a meta-analysis |
3 |
| Correlation between uterine artery Doppler and the sFlt-1/PlGF ratio in different phenotypes of placental dysfunction |
2 |
| Screening of serum biomarkers of preeclampsia by proteomics combination with bioinformatics |
2 |
| The association between abnormal coagulation testing in preeclampsia, adverse pregnancy outcomes, and placental histopathology |
2 |
| Correlates of neutrophil/lymphocyte, platelet/lymphocyte, and platelet/neutrophil ratios of neonates of women with hypertensive disease of pregnancy with neonatal birth outcomes |
2 |
| Pre-existing medical disorders as risk factors for preeclampsia: an exploratory case-control study |
2 |
| Effects of in vitro culture at the preimplantation embryo stage on early development and hypertension in ISIAH rats |
2 |
| Negative association between serum adropin and hypertensive disorders complicating pregnancy |
2 |
| CoQ10 alleviate preeclampsia symptoms by enhancing the function of mitochondria in the placenta of pregnant rats with preeclampsia |
2 |
| Maternal serum sestrin 2 levels in preeclampsia and their relationship with the severity of the disease |
2 |
| A meta-analysis of tumor necrosis factor-alpha and FAS/FASL polymorphisms with risk of pre-eclampsia |
2 |
| Associations of hypertensive disorders of pregnancy and outcomes of labor induction with prostaglandin vaginal inserts |
2 |
| Serum heme oxygenase 1 (HO-1), soluble FMS like tyrosine kinase (sFlt-1) level, and neonatal outcome in early onset, late onset preeclampsia, and normal pregnancy |
2 |
| Maternal levels of growth differentiation factor-15 in patients with preeclampsia |
2 |
| Arterial stiffness during controlled ovarian hyperstimulation and early pregnancy in women exposed to assisted reproduction |
2 |
| Neuropathological complications associated with hypertensive disorders of pregnancy |
2 |
| First versus second trimester mean platelet volume and uric acid for prediction of preeclampsia in women at moderate and low risk |
2 |
| The association of hyperuricemia and immediate postpartum hypertension in women without a diagnosis of chronic hypertension |
2 |
| Uterine artery flow velocity waveforms before and after delivery in hypertensive disorders of pregnancy near term |
2 |
| Urinary clusterin and glutathione-s-transferase levels in HIV positive normotensive and preeclamptic pregnancies |
1 |
| Serum magnesium level in the first trimester of pregnancy as a predictor of pre-eclampsia - a pilot study |
1 |
| The value of the 24-h proteinuria in evaluating the severity of preeclampsia and predicting its adverse maternal outcomes |
1 |
| Cardiovascular risk after preeclampsia: The effect of communicating risk factors on intended healthy behavior |
1 |
| Association between serum CA125 levels in preeclampsia and its severity among women in Lagos, South-West Nigeria |
1 |
| Relation of locus 1p13 rs646776 polymorphism with the risk of preeclampsia |
1 |
| Serial profile of flow-mediated dilatation in primigravida for prediction of preeclampsia and gestational hypertension |
1 |
| Peripheral arterial tonometry and angiogenic biomarkers in preeclampsia |
1 |
| Relation with postpartum maternal morbidity of different types of anesthesia in preeclamptic patients |
1 |
| The effect of magnesium sulfate on gene expression in maternal microvascular endothelial cells |
1 |
| Identification of key transcription factors in preeclampsia |
1 |
| Longitudinal changes in placental biomarkers in women with early versus late placental dysfunction |
1 |
| Longitudinal assessment of D-dimer and plasminogen activator inhibitor type-1 plasma levels in pregnant women with risk factors for preeclampsia |
1 |
| T lymphocytes in the third trimester decidua in preeclampsia |
1 |
